Cargando…
Thebromine Targets Adenosine Receptors to Control Hippocampal Neuronal Function and Damage
Theobromine is a caffeine metabolite most abundant in dark chocolate, of which consumption is linked with a lower risk of cognitive decline. However, the mechanisms through which theobromine affects neuronal function remain ill-defined. Using electrophysiological recordings in mouse hippocampal syna...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502181/ https://www.ncbi.nlm.nih.gov/pubmed/36142422 http://dx.doi.org/10.3390/ijms231810510 |
_version_ | 1784795642758955008 |
---|---|
author | Valada, Pedro Alçada-Morais, Sofia Cunha, Rodrigo A. Lopes, João Pedro |
author_facet | Valada, Pedro Alçada-Morais, Sofia Cunha, Rodrigo A. Lopes, João Pedro |
author_sort | Valada, Pedro |
collection | PubMed |
description | Theobromine is a caffeine metabolite most abundant in dark chocolate, of which consumption is linked with a lower risk of cognitive decline. However, the mechanisms through which theobromine affects neuronal function remain ill-defined. Using electrophysiological recordings in mouse hippocampal synapses, we now characterized the impact of a realistic concentration of theobromine on synaptic transmission and plasticity. Theobromine (30 μM) facilitated synaptic transmission while decreasing the magnitude of long-term potentiation (LTP), with both effects being blunted by adenosine deaminase (2 U/mL). The pharmacological blockade of A(1)R with DPCPX (100 nM) eliminated the theobromine-dependent facilitation of synaptic transmission, whereas the A(2A)R antagonist SCH58261 (50 nM), as well as the genetic deletion of A(2A)R, abrogated the theobromine-induced impairment of LTP. Furthermore, theobromine prevented LTP deficits and neuronal loss, respectively, in mouse hippocampal slices and neuronal cultures exposed to Aβ(1–42) peptides, considered a culprit of Alzheimer’s disease. Overall, these results indicate that theobromine affects information flow via the antagonism of adenosine receptors, normalizing synaptic plasticity and affording neuroprotection in dementia-related conditions in a manner similar to caffeine. |
format | Online Article Text |
id | pubmed-9502181 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95021812022-09-24 Thebromine Targets Adenosine Receptors to Control Hippocampal Neuronal Function and Damage Valada, Pedro Alçada-Morais, Sofia Cunha, Rodrigo A. Lopes, João Pedro Int J Mol Sci Article Theobromine is a caffeine metabolite most abundant in dark chocolate, of which consumption is linked with a lower risk of cognitive decline. However, the mechanisms through which theobromine affects neuronal function remain ill-defined. Using electrophysiological recordings in mouse hippocampal synapses, we now characterized the impact of a realistic concentration of theobromine on synaptic transmission and plasticity. Theobromine (30 μM) facilitated synaptic transmission while decreasing the magnitude of long-term potentiation (LTP), with both effects being blunted by adenosine deaminase (2 U/mL). The pharmacological blockade of A(1)R with DPCPX (100 nM) eliminated the theobromine-dependent facilitation of synaptic transmission, whereas the A(2A)R antagonist SCH58261 (50 nM), as well as the genetic deletion of A(2A)R, abrogated the theobromine-induced impairment of LTP. Furthermore, theobromine prevented LTP deficits and neuronal loss, respectively, in mouse hippocampal slices and neuronal cultures exposed to Aβ(1–42) peptides, considered a culprit of Alzheimer’s disease. Overall, these results indicate that theobromine affects information flow via the antagonism of adenosine receptors, normalizing synaptic plasticity and affording neuroprotection in dementia-related conditions in a manner similar to caffeine. MDPI 2022-09-10 /pmc/articles/PMC9502181/ /pubmed/36142422 http://dx.doi.org/10.3390/ijms231810510 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Valada, Pedro Alçada-Morais, Sofia Cunha, Rodrigo A. Lopes, João Pedro Thebromine Targets Adenosine Receptors to Control Hippocampal Neuronal Function and Damage |
title | Thebromine Targets Adenosine Receptors to Control Hippocampal Neuronal Function and Damage |
title_full | Thebromine Targets Adenosine Receptors to Control Hippocampal Neuronal Function and Damage |
title_fullStr | Thebromine Targets Adenosine Receptors to Control Hippocampal Neuronal Function and Damage |
title_full_unstemmed | Thebromine Targets Adenosine Receptors to Control Hippocampal Neuronal Function and Damage |
title_short | Thebromine Targets Adenosine Receptors to Control Hippocampal Neuronal Function and Damage |
title_sort | thebromine targets adenosine receptors to control hippocampal neuronal function and damage |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502181/ https://www.ncbi.nlm.nih.gov/pubmed/36142422 http://dx.doi.org/10.3390/ijms231810510 |
work_keys_str_mv | AT valadapedro thebrominetargetsadenosinereceptorstocontrolhippocampalneuronalfunctionanddamage AT alcadamoraissofia thebrominetargetsadenosinereceptorstocontrolhippocampalneuronalfunctionanddamage AT cunharodrigoa thebrominetargetsadenosinereceptorstocontrolhippocampalneuronalfunctionanddamage AT lopesjoaopedro thebrominetargetsadenosinereceptorstocontrolhippocampalneuronalfunctionanddamage |